Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIRCERA dosing in pediatric renal anemia
NCT00717366Phase 2Completed
- Sponsor
- Roche
- Start
- Jul 2008
- Primary completion
- Mar 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 12
01
Overview
A Phase 2 trial of methoxy polyethylene glycol-epoetin beta in anemia of chronic kidney disease, sponsored by Roche. Started Jul 2008; status: completed.
02
Drugs
methoxy polyethylene glycol-epoetin beta
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT00717366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00717366.